{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T23:00:03Z","timestamp":1788044403610,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jaip.2023.09.003","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T05:38:58Z","timestamp":1694756338000},"page":"3772-3779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)\u2014A Bicenter Retrospective Study on Diagnosis, Course, and Therapy"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9231-8504","authenticated-orcid":false,"given":"Susanne","family":"Trainotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janina","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Hofauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Greve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Wollenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas K.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Lochbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2023.09.003_bib1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/01.md.0000085055.63483.09","article-title":"Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies","volume":"82","author":"Cicardi","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2023.09.003_bib2","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jaip.2016.12.032","article-title":"Diagnosis, course, and management of angioedema in patients with acquired C1-inhibitor deficiency","volume":"5","author":"Zanichelli","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.09.003_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/cei.12910","article-title":"Comparing acquired angioedema with hereditary angioedema (types I\/II): findings from the Icatibant Outcome Survey","volume":"188","author":"Longhurst","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2023.09.003_bib4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9343(02)01124-5","article-title":"Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2","volume":"113","author":"Fremeaux-Bacchi","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2023.09.003_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1515\/cclm-2015-0195","article-title":"The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity","volume":"54","author":"Wu","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jaip.2023.09.003_bib6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.critrevonc.2013.02.004","article-title":"Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship","volume":"87","author":"Castelli","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jaip.2023.09.003_bib7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00005792-199207000-00003","article-title":"Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients","volume":"71","author":"Agostoni","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2023.09.003_bib8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.iac.2006.08.002","article-title":"Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management","volume":"26","author":"Zingale","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2023.09.003_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1710-1492-6-14","article-title":"Acquired angioedema","volume":"6","author":"Cicardi","year":"2010","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2023.09.003_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113844","article-title":"A\u00a0robust multiplexed assay to quantify C1-inhibitor, C1q, and C4 proteins for in\u00a0vitro diagnosis of hereditary angioedema from dried blood spot","volume":"195","author":"Lai","year":"2021","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.jaip.2023.09.003_bib11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.alit.2017.03.008","article-title":"Diminished capacity of opsonization and immune complex solubilization, and detection of anti-C1q antibodies in sera from patients with hereditary angioedema","volume":"66","author":"Honda","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2023.09.003_bib12","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s10875-012-9691-2","article-title":"Acquired C1-inhibitor deficiency: 7 patients treated with rituximab","volume":"32","author":"Branellec","year":"2012","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2023.09.003_bib13","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1159\/000512933","article-title":"Acquired angioedema with C1 inhibitor deficiency: occurrence, clinical features, and management: a nationwide retrospective study in the Czech Republic patients","volume":"182","author":"Sobotkova","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.09.003_bib14","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1172\/JCI114084","article-title":"Acquired C1 inhibitor (C1-INH) deficiency type II: replacement therapy with C1-INH and analysis of patients\u2019 C1-INH and anti-C1-INH autoantibodies","volume":"83","author":"Alsenz","year":"1989","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2023.09.003_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13023-019-1043-3","article-title":"Angioedema due to acquired C1-inhibitor deficiency: spectrum and treatment with C1-inhibitor concentrate","volume":"14","author":"Bork","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaip.2023.09.003_bib16","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/j.jaip.2021.01.040","article-title":"Efficacy of lanadelumab in acquired angioedema with C1-inhibitor deficiency","volume":"9","author":"Belbezier","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.09.003_bib17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0091-6749(78)90210-5","article-title":"Acquired angioedema associated with rectal carcinoma and its response to danazol therapy: acquired angioedema treated with danazol","volume":"62","author":"Cohen","year":"1978","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.09.003_bib18","doi-asserted-by":"crossref","first-page":"e4363","DOI":"10.1097\/MD.0000000000004363","article-title":"A\u00a0nationwide study of acquired C1-inhibitor deficiency in France: characteristics and treatment responses in 92 patients","volume":"95","author":"Gobert","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2023.09.003_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.18176\/jiaci.0635","article-title":"Successful use of recombinant human C1-INH in a patient with acquired angioedema due to C1 inhibitor deficiency and an unusually high titer of anti-C1-inhibitor autoantibodies","volume":"31","author":"Jesenak","year":"2021","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2023.09.003_bib20","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1398-9995.2012.02853.x","article-title":"Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study","volume":"67","author":"Zanichelli","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.09.003_bib21","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jaip.2021.11.018","article-title":"Angioedema due to acquired deficiency of C1-inhibitor: a cohort study in Spain and a comparison with other series","volume":"10","author":"Baeza","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.09.003_bib22","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1111\/all.15214","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema\u2014the 2021 revision and update","volume":"77","author":"Maurer","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.09.003_bib23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/joim.13182","article-title":"A\u00a0follow-up survey of patients with acquired angioedema due to C1-inhibitor deficiency","volume":"289","author":"Polai","year":"2021","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jaip.2023.09.003_bib24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/cei.13361","article-title":"Serum complexes between C1INH and C1INH autoantibodies for the diagnosis of acquired angioedema","volume":"198","author":"Lopez-Lera","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2023.09.003_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13601-018-0229-4","article-title":"Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey","volume":"8","author":"Zanichelli","year":"2018","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2023.09.003_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13601-019-0272-9","article-title":"Elderly versus younger patients with hereditary angioedema type I\/II: patient characteristics and safety analysis from the Icatibant Outcome Survey","volume":"9","author":"Bygum","year":"2019","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2023.09.003_bib27","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1159\/000514973","article-title":"Prophylactic treatment in hereditary angioedema is associated with reduced anxiety in patients in Leipzig, Germany","volume":"182","author":"Zarnowski","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.09.003_bib28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13023-020-01506-5","article-title":"A\u00a0Germany-wide survey study on the patient journey of patients with hereditary angioedema","volume":"15","author":"Magerl","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaip.2023.09.003_bib29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000351452","article-title":"Acquired angioedema--occurrence, clinical features and associated disorders in a Danish nationwide patient cohort","volume":"162","author":"Bygum","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.09.003_bib30","first-page":"315","article-title":"Successful rituximab B lymphocyte depletion therapy for angioedema due to acquired C1 inhibitor protein deficiency: association with reduced C1 inhibitor protein autoantibody titers","volume":"16","author":"Dreyfus","year":"2014","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.jaip.2023.09.003_bib31","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2340\/00015555-1157","article-title":"Acquired angioedema responding to rituximab","volume":"91","author":"Hassan","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2023.09.003_bib32","first-page":"165","article-title":"Rituximab therapy in a patient with low grade B-cell lymphoproliferative disease and concomitant acquired angioedema","volume":"7","author":"Kaur","year":"2014","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.jaip.2023.09.003_bib33","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/all.13686","article-title":"Long-term effects upon rituximab treatment of acquired angioedema due to C1-inhibitor deficiency","volume":"74","author":"Levi","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.09.003_bib34","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2500\/aap.2021.42.200127","article-title":"Assessing the cost and quality-of-life impact of on-demand-only medications for adults with hereditary angioedema","volume":"42","author":"Castaldo","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2023.09.003_bib35","first-page":"978","article-title":"Prospective analysis in patients with HAE under prophylaxis with lanadelumab: a real-life experience","volume":"19","author":"Hahn","year":"2020","journal-title":"J\u00a0Drugs Dermatol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823010115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823010115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T01:24:04Z","timestamp":1716427444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823010115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2213219823010115"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2023.09.003","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)\u2014A Bicenter Retrospective Study on Diagnosis, Course, and Therapy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2023.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}